About this trial
Because Propofol is the primary "anesthetic agent," and inhalational agents remain in trace quantities at the end of the procedure Sevoflurane initiated intravenous anesthesia (SIIVA) or not present at all Total intravenous anesthesia (TIVA) it is likely that different criteria may be predictive of extubation success in these patients compared to inhalational anesthesia.
Eligibility criteria
Qualifiers
Pediatric patients <10 years of age
Undergoing elective or emergency surgery with planned airway instrumentation with an endotracheal tube (ETT)
Patients having general anesthesia with a planned SIIVA or TIVA technique
Patients with an end tidal agent concentration of Sevoflurane<0.1% at the time of emergence and extubation
Disqualifiers
History of home oxygen use or ventilator dependence
Patients with cyanotic congenital heart disease
Patients undergoing anesthesia for imaging procedures alone
Patients intended to be managed with supraglottic airway
Trial design
Treatments tested in this trial
- Total intravenous anesthesia (TIVA)
- Sevoflurane initiated intravenous anesthesia (SIIVA)